June 6, 2022
Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment